Dr Tara Rose Hogan, MD in Boston, MA - Medicare Student in an Organized Health Care Education/Training Program

Dr Tara Rose Hogan, MD is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Boston, Massachusetts. Her current practice location is 330 Brookline Ave, Boston, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (617) 632-9236.

Dr Tara Rose Hogan is licensed to practice in Massachusetts (license number 280377) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1215597810.

Contact Information

	Dr Tara Rose Hogan, MD
	330 Brookline Ave, Boston, MA 02215-5491
	(617) 632-9236
	Not Available

Physician's Profile

Full Name	Dr Tara Rose Hogan
Gender	Female
Speciality	Student In An Organized Health Care Education/training Program
Location	330 Brookline Ave, Boston, Massachusetts
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1215597810
Provider Enumeration Date: 06/17/2019
Last Update Date: 06/23/2019

Medicare PECOS Information:

PECOS PAC ID: 9133454572
Enrollment ID: I20190708002428

Medical Identifiers

Medical identifiers for Dr Tara Rose Hogan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1215597810	NPI	-	NPPES
280377	Other	MA	MASSACHUSETTS STATE MEDICAL LICENSE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	280377 (Massachusetts)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	280377 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Tara Rose Hogan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Tara Rose Hogan, MD 330 Brookline Ave, Boston, MA 02215-5400 Ph: (617) 667-7000	Dr Tara Rose Hogan, MD 330 Brookline Ave, Boston, MA 02215-5491 Ph: (617) 632-9236

News Archive

Linagliptin may reduce brain damage following stroke in type 2 diabetic patients

In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.

Researchers reveal how schizophrenia-linked genetic variation alters skeletons of developing brain cells

Johns Hopkins researchers have begun to connect the dots between a schizophrenia-linked genetic variation and its effect on the developing brain. As they report July 3 in the journal Cell Stem Cell, their experiments show that the loss of a particular gene alters the skeletons of developing brain cells, which in turn disrupts the orderly layers those cells would normally form.

BioAxial receives US patent for new ‘black fluorophore' technology

BioAxial, a key player in live cell super resolution microscopy, today announces that it has been granted a US patent covering ‘black fluorophore', a pivotal component of ‘dark tracking' technology. This patent consolidates BioAxial's patent portfolio, which already comprises ten patent families. It also strengthens the company's position as a technology leader in the field of commercial super-resolution imaging modules.

Low-income settings require local guideline development for childhood illness

The next generation of case management guidelines for childhood illness need to be more locally informed, rather than relying on those centrally generated by organizations like the World Health Organization (WHO), argues a new essay published in the open access journal PLoS Medicine.

Researchers isolate protective antibodies for rare, polio-like disease in children

Researchers at Vanderbilt University Medical Center, Purdue University and the University of Wisconsin-Madison have isolated human monoclonal antibodies that potentially can prevent a rare but devastating polio-like illness in children linked to a respiratory viral infection.

Dr Tara Rose Hogan, MD - Medicare Student in an Organized Health Care Education/Training Program in Boston, MA